PTEN loss is two- to five-times more frequent among ERG-positive compared to ERG-negative tumors and we and other groups have reported that PTEN loss occurs subsequent to ERG rearrangement in the majority of prostate tumors [30–33]. Here, PTEN is linked to prostate neoplasm.